Evonile Pharma Ltd

NSE: NOVARTIND · BSE: 500672 · Pharmaceuticals & Biotechnology · 48 announcements

Share price

₹1,573.25

Market cap

₹3,884 Cr

Revenue (annual)

₹354.3 Cr

Net profit (annual)

₹93.18 Cr

P/E (TTM)

-973.5×Sector 43.8×

Promoter holding

70.68%+0.00% QoQ

FII holding

1.21%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.